Track topics on Twitter Track topics that are important to you
Rare disease firm Therachon AG is acquiring closely held GLyPharma Therapeutic Inc. for an undisclosed sum.
Rare disease-focused Therachon AG raised $60mm in a mezzanine financing led by Novo Holdings, which was joined by other new backers Cowen Healthcare Investments, Pfizer Ventures, and Tekla Capital Man...
The Basel, Switzerland-based biotech company plans to trial the drug in achondroplasia patients next year.
Therachon AG, a clinical-stage biotechnology company focused on rare diseases, today announced the start of “Dreambird,” a natural history study of children with achondroplasi...
- Jørgen Søberg Petersen, M.D., Ph.D., DMSc, MBA and Timothy Anderson to Join Board of Directors - Therachon AG, a clinical-stage biotechnology company focused on rare ...
Therachon is developing an innovative therapy for achondroplasia, the leading cause of dwarfism in humans. Therachonâs therapy aims to restore normal bone growth and proporti...
Therachon is a clinical-stage global biotechnology company focused on developing medicines for rare diseases with significant unmet need. The companyâs lead pipeline candidat...
We have published hundreds of Therachon AG news stories on BioPortfolio along with dozens of Therachon AG Clinical Trials and PubMed Articles about Therachon AG for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Therachon AG Companies in our database. You can also find out about relevant Therachon AG Drugs and Medications on this site too.
Bioscience - any of the sciences that deal with living organisms. The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...